Vanda Pharmaceuticals sues U.S. government over drug trade secrets
By Blake Brittain (Reuters) – Vanda Pharmaceuticals Inc has sued
pharmaceuticals
Canada September wholesale trade up 0.1% on pharmaceuticals
Nov 15 (Reuters) – Canadian wholesale trade increased by 0.1%
Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022
XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and PLENVU® Research Posters Will Be
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) launches Luzsana Biotechnology™ (Luzsana)
Luzsana to co-develop medicines with parent company Hengrui Pharma and
NRX PHARMACEUTICALS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of NRx Pharmaceuticals, Inc. – NRXP
NEW ORLEANS, April 22, 2022 — Former Attorney General of
SALIX PHARMACEUTICALS WILL PRESENT SCIENTIFIC DATA AT THE SOCIETY OF HOSPITAL MEDICINE CONVERGE 2022
Featured Posters Will Include XIFAXAN® (rifaximin) and RELISTOR® (methylnaltrexone bromide)
Avet Pharmaceuticals Announces Approval and Launch of Propofol Injectable Emulsion, USP
Avet Pharma Announces Approval and Launch of Propofol Injectable Emulsion,
Injectable Drug Delivery Market Size to Reach USD 83.38 Billion in 2030 | Convenience and At-Home Accessibility Afforded by Injectable Pharmaceuticals are Key Factors Driving Industry Demand, Says Emergen Research
VANCOUVER, BC, March 30, 2022 — The global injectable drug delivery
Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. launch Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/325 mg/40 mg in the U.S. market USA – English USA – English
“We are pleased to collaborate with Seton Pharmaceuticals for the